Barbara Campanini Selected Research

serine racemase

4/2022	Human Serine Racemase Weakly Binds the Third PDZ Domain of PSD-95.
1/2018	The Energy Landscape of Human Serine Racemase.
1/2018	Glutamine 89 is a key residue in the allosteric modulation of human serine racemase activity by ATP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Campanini Research Topics

Disease

5	Infections 06/2022 - 01/2013
3	Dehydration (Water Stress) 04/2022 - 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Lactose Intolerance (Intolerance, Lactose) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Bacterial Infections (Bacterial Infection) 12/2018
1	Decompression Sickness (Bends) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2016
1	Persistent Infection 01/2015
1	Mental Disorders (Mental Disorder) 01/2013
1	Schizophrenia (Dementia Praecox) 06/2011
1	Cysts 12/2006

Drug/Important Bio-Agent (IBA)

6	Cysteine (L-Cysteine)FDA Link 02/2021 - 12/2006
4	Pyruvic Acid (Pyruvate)IBA 04/2022 - 12/2006
4	Serine (L-Serine)FDA Link 04/2022 - 01/2013
4	AmmoniaIBA 04/2022 - 12/2006
4	EnzymesIBA 01/2022 - 12/2006
3	serine racemaseIBA 04/2022 - 01/2018
2	Cysteine SynthaseIBA 06/2022 - 12/2021
2	Colistin (Coly-Mycin)FDA Link 06/2022 - 12/2021
2	PyridoxalIBA 01/2018 - 12/2006
2	Protein Isoforms (Isoforms)IBA 01/2013 - 06/2011
1	CollagenIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	IsoenzymesIBA 01/2013
1	LigandsIBA 01/2013
1	cysteine persulfideIBA 12/2006
1	LyasesIBA 12/2006
1	Cystine (L-Cystine)IBA 12/2006

Therapy/Procedure

1	Enzyme Replacement Therapy 01/2022
1	Therapeutics 01/2022